المؤلفون: Hsu C; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Hutt E; Insocius Ltd, London, United Kingdom., Bloomfield DM; Anthos Therapeutics, Cambridge, Massachusetts, USA., Gailani D; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Weitz JI; Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada; Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada. Electronic address: weitzj@taari.ca.

المصدر: Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 Aug 10; Vol. 78 (6), pp. 625-631.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Hemostasis*/drug effects , Hemostasis*/physiology , Thrombosis*/blood , Thrombosis*/drug therapy, Factor Xa Inhibitors/*pharmacology, Blood Coagulation/drug effects ; Blood Coagulation/physiology ; Humans

المؤلفون: Richards DA; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA (D.A.R., M.J.A., G.L.M., K.T., S.P., R.H.K., R.M.B.)., Aronovitz MJ; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA (D.A.R., M.J.A., G.L.M., K.T., S.P., R.H.K., R.M.B.)., Liu P; Graduate School of Biomedical Sciences, Tufts University, Boston, MA (P.L., R.M.B.)., Martin GL; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA (D.A.R., M.J.A., G.L.M., K.T., S.P., R.H.K., R.M.B.)., Tam K; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA (D.A.R., M.J.A., G.L.M., K.T., S.P., R.H.K., R.M.B.)., Pande S; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA (D.A.R., M.J.A., G.L.M., K.T., S.P., R.H.K., R.M.B.)., Karas RH; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA (D.A.R., M.J.A., G.L.M., K.T., S.P., R.H.K., R.M.B.)., Bloomfield DM; Cardurion Pharmaceuticals, Inc, Boston, MA (D.M.B., M.E.M.)., Mendelsohn ME; Cardurion Pharmaceuticals, Inc, Boston, MA (D.M.B., M.E.M.)., Blanton RM; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA (D.A.R., M.J.A., G.L.M., K.T., S.P., R.H.K., R.M.B.).; Graduate School of Biomedical Sciences, Tufts University, Boston, MA (P.L., R.M.B.).

المصدر: Circulation. Heart failure [Circ Heart Fail] 2021 Jan; Vol. 14 (1), pp. e007300. Date of Electronic Publication: 2021 Jan 19.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101479941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-3297 (Electronic) Linking ISSN: 19413289 NLM ISO Abbreviation: Circ Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: 3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors , Heart/*drug effects , Heart Failure/*physiopathology , Hypertrophy, Left Ventricular/*physiopathology , Phosphodiesterase Inhibitors/*pharmacology , Stroke Volume/*drug effects , Ventricular Remodeling/*drug effects, Animals ; Aorta/surgery ; Carrier Proteins/drug effects ; Carrier Proteins/metabolism ; Collagen/drug effects ; Collagen/metabolism ; Constriction, Pathologic ; Cyclic GMP/blood ; Cyclic GMP-Dependent Protein Kinase Type I/drug effects ; Cyclic GMP-Dependent Protein Kinase Type I/metabolism ; Fibrosis ; Heart/physiopathology ; Heart Atria/drug effects ; Heart Failure/pathology ; Heart Ventricles/drug effects ; Heart Ventricles/metabolism ; Heart Ventricles/pathology ; Hypertrophy, Left Ventricular/pathology ; Lung/drug effects ; Male ; Mice ; Organ Size ; Phosphorylation/drug effects ; Pulmonary Edema/physiopathology

المؤلفون: Beldhuis IE; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., Streng KW; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., van der Meer P; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., Ter Maaten JM; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA, USA., Metra M; University of Brescia, Brescia, Italy., Dittrich HC; Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa City, IA, USA., Ponikowski P; Klinika Kardiologii, Wroclaw, Poland., Cotter G; Momentum Research, Inc., Durham, NC, USA., Cleland JGF; National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, UK., Davison BA; Momentum Research, Inc., Durham, NC, USA., Givertz MM; Brigham and Women's Hospital, Boston, MA, USA., Teerlink JR; University of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA., Bloomfield DM; Merck & Co, Inc., Kenilworth, NJ, USA., Voors AA; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., Damman K; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: k.damman@umcg.nl.

المصدر: Journal of cardiac failure [J Card Fail] 2019 Nov; Vol. 25 (11), pp. 866-874. Date of Electronic Publication: 2019 Jul 15.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Observational Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: United States NLM ID: 9442138 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8414 (Electronic) Linking ISSN: 10719164 NLM ISO Abbreviation: J Card Fail Subsets: MEDLINE

مواضيع طبية MeSH: Glomerular Filtration Rate/*physiology , Heart Failure/*mortality , Heart Failure/*physiopathology , Kidney/*physiology , Kidney Diseases/*mortality , Kidney Diseases/*physiopathology, Acute Disease ; Aged ; Aged, 80 and over ; Double-Blind Method ; Female ; Heart Failure/diagnosis ; Humans ; Kidney Diseases/diagnosis ; Male ; Middle Aged ; Retrospective Studies ; Survival Rate/trends

المؤلفون: Rubio-Gracia J; Servicio de Medicina Interna, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain; Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., Demissei BG; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., Ter Maaten JM; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., Cleland JG; Imperial College, London, UK., O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA, USA., Metra M; University of Brescia, Brescia, Italy., Ponikowski P; Medical University, Clinical Military Hospital, Wroclaw, Poland., Teerlink JR; University of California at San Francisco, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA., Cotter G; Momentum Research Inc., Durham, NC, USA., Davison BA; Momentum Research Inc., Durham, NC, USA., Givertz MM; Brigham and Women's Hospital, Boston, MA, USA., Bloomfield DM; Merck & Co., Inc. Kenilworth, NJ, USA., Dittrich H; Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa, USA., Damman K; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands., Pérez-Calvo JI; Servicio de Medicina Interna, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain; Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain., Voors AA; University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.. Electronic address: a.a.voors@umcg.nl.

المصدر: International journal of cardiology [Int J Cardiol] 2018 May 01; Vol. 258, pp. 185-191.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8200291 Publication Model: Print Cited Medium: Internet ISSN: 1874-1754 (Electronic) Linking ISSN: 01675273 NLM ISO Abbreviation: Int J Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure/*diagnosis , Heart Failure/*epidemiology, Acute Disease ; Adenosine A1 Receptor Antagonists/therapeutic use ; Aged ; Aged, 80 and over ; Female ; Heart Failure/drug therapy ; Humans ; Male ; Middle Aged ; Mortality ; Patient Readmission/trends ; Predictive Value of Tests ; Prevalence ; Treatment Outcome

المؤلفون: Metra M; Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Italy (M.M.)., Cotter G; Momentum Research Inc, Durham, NC (G.C., S.S., C.E., G.C.C., O.M., B.A.D.). gadcotter@momentum-research.com., Senger S; Momentum Research Inc, Durham, NC (G.C., S.S., C.E., G.C.C., O.M., B.A.D.)., Edwards C; Momentum Research Inc, Durham, NC (G.C., S.S., C.E., G.C.C., O.M., B.A.D.)., Cleland JG; Department of Cardiology, University of Hull, United Kingdom (J.G.C.)., Ponikowski P; Department of Cardiology, Medical University, Clinical Military Hospital, Wroclaw, Poland (P.P.)., Cursack GC; Momentum Research Inc, Durham, NC (G.C., S.S., C.E., G.C.C., O.M., B.A.D.)., Milo O; Momentum Research Inc, Durham, NC (G.C., S.S., C.E., G.C.C., O.M., B.A.D.)., Teerlink JR; University of California at San Francisco and San Francisco Veterans Affairs Medical Center (J.R.T.)., Givertz MM; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.M.G.)., O'Connor CM; Duke University Medical Center, Durham, NC (C.M.O.)., Dittrich HC; Independent Researcher (H.D.)., Bloomfield DM; Merck and Co, Inc, Rahway, NJ (D.M.B.)., Voors AA; University Medical Center, Department of Cardiology and Thorax Surgery, University of Groningen, The Netherlands (A.A.V.)., Davison BA; Momentum Research Inc, Durham, NC (G.C., S.S., C.E., G.C.C., O.M., B.A.D.).

المصدر: Circulation. Heart failure [Circ Heart Fail] 2018 May; Vol. 11 (5), pp. e004644.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101479941 Publication Model: Print Cited Medium: Internet ISSN: 1941-3297 (Electronic) Linking ISSN: 19413289 NLM ISO Abbreviation: Circ Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Creatinine/*blood , Heart Failure/*physiopathology , Heart Failure/*therapy , Patient Readmission/*statistics & numerical data, Acute Disease ; Aged ; Aged, 80 and over ; Female ; Heart Failure/diagnosis ; Hospitalization/statistics & numerical data ; Humans ; Kidney/physiopathology ; Male ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Xanthines/pharmacology

المؤلفون: Sharma A; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada., Demissei BG; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands., Tromp J; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Hillege HL; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands., Cleland JG; Imperial College, London, UK., O'Connor CM; Inova Heart and Vascular Institute, Fairfax, VA, USA., Metra M; University of Brescia, Brescia, Italy., Ponikowski P; Medical University, Clinical Military Hospital, Wroclaw, Poland., Teerlink JR; University of California at San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA., Davison BA; Momentum Research, Durham, NC, USA., Givertz MM; Brigham and Women's Hospital, Boston, MA, USA., Bloomfield DM; Merck & Co., Inc., Kenilworth, NJ, USA., Dittrich H; Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa City, IA, USA., van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Cotter G; Momentum Research, Durham, NC, USA., Ezekowitz JA; Department of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada., Khan MAF; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Experimental Cardiology, Academic Medical Center, Amsterdam, The Netherlands.; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Amsterdam, The Netherlands., Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

المصدر: European journal of heart failure [Eur J Heart Fail] 2017 Oct; Vol. 19 (10), pp. 1310-1320. Date of Electronic Publication: 2017 Jun 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus/*blood , Diabetes Mellitus/*physiopathology , Heart Failure/*blood , Heart Failure/*physiopathology, Acute Disease ; Biomarkers/blood ; Humans

المؤلفون: Damman K; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen 9712, The Netherlands. k.damman@umcg.nl., Valente MAE; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen 9712, The Netherlands. m.a.e.valente@umcg.nl., van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen 9712, The Netherlands. d.j.van.veldhuisen@umcg.nl., Cleland JGF; Imperial College London, London SW7 2AZ, UK. j.cleland@imperial.ac.uk., O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA 22042, USA. Christopher.Oconnor@inova.org., Metra M; University of Brescia, Brescia 25121, Italy. metramarco@libero.it., Ponikowski P; Medical University, Clinical Military Hospital, Wroclaw 50-981, Poland. piotrponikowski@4wsk.pl., Cotter G; Momentum Research, Durham, NC 27707, USA. GadCotter@momentum-research.com., Davison B; Momentum Research, Durham, NC 27707, USA. bethdavison@momentum-research.com., Givertz MM; Brigham and Women's Hospital, Boston, MA 02115, USA. MGIVERTZ@PARTNERS.ORG., Bloomfield DM; Merck Research Laboratories, Rahway, NJ 07065, USA. dbloomfield1@gmail.com., Hillege HL; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen 9712, The Netherlands. h.hillege@umcg.nl.; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen 9712, The Netherlands. h.hillege@umcg.nl., Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen 9712, The Netherlands. A.a.voors@umcg.nl.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2017 Jul 08; Vol. 18 (7). Date of Electronic Publication: 2017 Jul 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Acute Kidney Injury/*blood , Acute Kidney Injury/*physiopathology , Biomarkers/*blood , Kidney/*metabolism , Kidney/*pathology , Lipocalin-2/*blood, Aged ; Creatinine/blood ; Female ; Heart Failure/blood ; Humans ; Kidney/physiopathology ; Kidney Function Tests ; Male ; Middle Aged

المؤلفون: Tromp J; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Khan MAF; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Heart Failure Research Centre, Academic Medical Centre, Amsterdam, the Netherlands., Mentz RJ; Duke University Medical Center, Durham, North Carolina., O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia., Metra M; University of Brescia, Brescia, Italy., Dittrich HC; Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa City, Iowa., Ponikowski P; Medical University, Clinical Military Hospital, Wroclaw, Poland., Teerlink JR; University of California at San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California., Cotter G; Momentum Research, Durham, North Carolina., Davison B; Momentum Research, Durham, North Carolina., Cleland JGF; University of Hull, Kingston upon Hull, United Kingdom., Givertz MM; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Bloomfield DM; Merck & Co., Inc., Kenilworth, New Jersey., Van Veldhuisen DJ; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Hillege HL; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Voors AA; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: a.a.voors@umcg.nl., van der Meer P; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

المصدر: JACC. Heart failure [JACC Heart Fail] 2017 Jul; Vol. 5 (7), pp. 507-517. Date of Electronic Publication: 2017 Jun 14.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers/*metabolism , Heart Failure/*blood, Acute Disease ; Aged ; Female ; Heart Failure/mortality ; Heart Failure/physiopathology ; Hospitalization/statistics & numerical data ; Humans ; Male ; Prognosis ; Recurrence ; Stroke Volume/physiology

المؤلفون: Cowie MR; National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, Sydney Street, London, SW3 6HP, UK., Filippatos GS; National and Kapodistrian University of Athens, School of Medicine, Athens University Hospital Attikon, Athens, Greece., Alonso Garcia MLA; National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, Sydney Street, London, SW3 6HP, UK.; Scientific Advice Working Party European Medicines Agency, Medical Assessor Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK., Anker SD; Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Centre Göttingen (UMG), Göttingen, Germany.; Division of Homeostasis Research, Dept of Cardiology, Charité Campus CVK, Berlin, Germany., Baczynska A; European Medicines Agency, London, UK., Bloomfield DM; Merck & Co., Inc., Kenilworth, NJ, USA., Borentain M; Bristol-Myers Squibb, Rueil-Malmaison, France., Bruins Slot K; Norwegian Medicines Agency, Oslo, Norway., Cronin M; Vifor Pharma, Zurich, Switzerland., Doevendans PA; European Medicines Agency Committee for Advanced Therapy, London, UK.; UMC, Utrecht, the Netherlands., El-Gazayerly A; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, the Netherlands., Gimpelewicz C; Novartis Pharmaceuticals, Basel, Switzerland., Honarpour N; Amgen, Inc., Thousand Oaks, CA, USA., Janmohamed S; GlaxoSmithKline, Stockley Park, UK., Janssen H; European Medicines Agency, London, UK., Kim AM; Pfizer, Inc., Cambridge, MA, USA., Lautsch D; Merck & Co., Inc., Kenilworth, NJ, USA., Laws I; GlaxoSmithKline, London, UK., Lefkowitz M; Novartis Pharmaceuticals, East Hanover, New Jersey, United States., Lopez-Sendon J; Cardiology Department, Hospital Universitario La Paz; IdiPaz, CIBER-CV, Madrid, Spain., Lyon AR; National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, Sydney Street, London, SW3 6HP, UK., Malik FI; Cytokinetics, South San Francisco, CA, USA., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK., Metra M; Cardiology, University of Brescia, Brescia, Italy., Figueroa Perez S; Bayer Pharma AG, Wuppertal, Germany., Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Pocock SJ; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Ponikowski P; Department of Heart Diseases, Medical University, Military Hospital, Wroclaw, Poland., Prasad K; United Kingdom Medicines and Healthcare Products Regulatory Agency, London, UK., Richard-Lordereau I; Bristol-Myers Squibb, Paris, France., Roessig L; Bayer Pharma AG, Wuppertal, Germany., Rosano GMC; IRCCS San Raffaele Hospital Roma, Rome, Italy.; Cardiovascular Clinical Academic Group, St George's Hospitals NHS Trust, University of London, London, UK., Sherman W; Celyad, Mont Saint Guibert, Belgium., Stough WG; Campbell University College of Pharmacy and Health Sciences, Cary, NC, USA., Swedberg K; National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, Sydney Street, London, SW3 6HP, UK.; Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Tyl B; Servier International, Paris, France., Zannad F; INSERM, Centre d'Investigation Clinique 1433 and Unité 1116, Université de Lorraine and CHU, Nancy, France., Boulton C; Novartis Pharmaceuticals, Basel, Switzerland., De Graeff P; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, the Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.

المصدر: European journal of heart failure [Eur J Heart Fail] 2017 Jun; Vol. 19 (6), pp. 718-727. Date of Electronic Publication: 2017 Mar 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials as Topic* , Outcome Assessment, Health Care*, Cardiovascular Agents/*therapeutic use , Heart Failure/*drug therapy, Consensus ; Drug Approval ; Humans

المؤلفون: Demissei BG; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands.; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Postmus D; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Cleland JG; Imperial College, London, UK., O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA, USA., Metra M; University of Brescia, Brescia, Italy., Ponikowski P; Medical University, Clinical Military Hospital, Wroclaw, Poland., Teerlink JR; University of California at San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA., Cotter G; Momentum Research Inc., Durham, NC, USA., Davison BA; Momentum Research Inc., Durham, NC, USA., Givertz MM; Brigham and Women's Hospital, Boston, MA, USA., Bloomfield DM; Merck and Company, Inc., Kenilworth, NJ, USA., van Veldhuisen DJ; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands., Dittrich HC; Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa City, IA, USA., Hillege HL; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands.; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Voors AA; Department of Cardiology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands.

المصدر: European journal of heart failure [Eur J Heart Fail] 2017 Jun; Vol. 19 (6), pp. 728-738. Date of Electronic Publication: 2017 Mar 01.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Patient Discharge*, Heart Failure/*blood , Natriuretic Peptide, Brain/*blood , Peptide Fragments/*blood , Purinergic P1 Receptor Antagonists/*therapeutic use , Renal Insufficiency, Chronic/*prevention & control , Risk Assessment/*methods, Biomarkers/blood ; Enzyme-Linked Immunosorbent Assay ; Female ; Heart Failure/drug therapy ; Heart Failure/mortality ; Humans ; Incidence ; Male ; Middle Aged ; Netherlands/epidemiology ; Patient Readmission/trends ; Prognosis ; ROC Curve ; Renal Insufficiency, Chronic/blood ; Renal Insufficiency, Chronic/epidemiology ; Survival Rate/trends